ERVW-1 and nasopharyngeal carcinoma: The fact that the JSRV Env monoclonal antibody did not cross-react with non-neoplastic lung tissue or nasopharyngeal carcinoma biopsies and only reacted strongly with a small subset of lung tumor samples suggests that the antibody is specific for an antigen present in human lung tumors.